Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is a biologically aggressive and diagnostically complex leukemia subtype—especially prevalent in pediatric and therapy-related ...
Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...
Health systems are entering an era of intelligent data management where real-time validation, data quality scoring and robust ...
In this special guest feature, Eric Sullivan, Senior Vice President, Innovation & Data Strategies at Inovalon, describes how data-driven platforms and patient-specific analytic insights drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback